exnessog
--
🚨 Profitable Trade Analysis
$VIC
{future}(VICUSDT)
Entry Zone 🎯
The recommended entry zone, according to the provided trade signal, is between $0.2330 and $0.2380. The current price shown in the first image is $0.2372, which falls within this recommended entry zone.
Take Profit (TP) Targets ✅
The trade signal provides three profit targets:
TP1: $0.2420
TP2: $0.2460
TP3: $0.2500
TP4: $0.2600
Stop Loss (SL) 🛑
A stop loss is crucial for risk management, For this trade, a potential stop loss could be below the lower end of the entry zone, for example, $0.2320 or a level where the chart indicates strong support.
SL should be use 0.22
📊 Market Context
The trading chart shows the Bollinger Bands (BOLL), which indicate price volatility. The price is currently near the middle band and appears to be in a downtrend. The Relative Strength Index (RSI) is at 25.3713, which is close to the oversold level (typically below 30), suggesting the price might be due for a bounce or a reversal.
$VIC
{future}(VICUSDT)
Entry Zone 🎯
The recommended entry zone, according to the provided trade signal, is between $0.2330 and $0.2380. The current price shown in the first image is $0.2372, which falls within this recommended entry zone.
Take Profit (TP) Targets ✅
The trade signal provides three profit targets:
TP1: $0.2420
TP2: $0.2460
TP3: $0.2500
TP4: $0.2600
Stop Loss (SL) 🛑
A stop loss is crucial for risk management, For this trade, a potential stop loss could be below the lower end of the entry zone, for example, $0.2320 or a level where the chart indicates strong support.
SL should be use 0.22
📊 Market Context
The trading chart shows the Bollinger Bands (BOLL), which indicate price volatility. The price is currently near the middle band and appears to be in a downtrend. The Relative Strength Index (RSI) is at 25.3713, which is close to the oversold level (typically below 30), suggesting the price might be due for a bounce or a reversal.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
225
0